Videos Steve Reitmeister shares details from a recent Zacks Rank performance study to help investors set realistic expectations. Articles You May Like Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors Point72’s Steve Cohen is stepping back from trading his own book Your favorite stocks may soon be quoted in half-penny increments – which could cut trading costs Top Wall Street analysts find these stocks promising for the long haul Apple Intelligence: Redefining AI With the Ultimate Assistant